New patent on synthetic molecules brings researchers closer to new - PowerPoint PPT Presentation

New patent on synthetic molecules brings researchers closer to new periodontitis treatment January 2016 Donald Demuth, Ph.D., associate dean for research and enterprise, UofL School of Dentistry, and Frederick Luzzio, Ph.D., professor, UofL College of Arts & Sciences, Department of Chemistry

UofL, Smile Kentucky provide children with free dental screenings February 2016

UL Additive Manufacturing Competency Center Opens February 2016

Portland site to house UofL Masters of Fine Arts program Rendering – Interior Portland February 2016

UofL received a Gold STARS rating from AASHE Association for the Advancement of Sustainability in Higher Education one of just 89 STARS Gold schools on the planet February 2016 the only STARS Gold school in Kentucky

UofL one of top universities for Fulbright awards March 2016 Since 2003 UofL has had 89 Fulbright winners More than all other Kentucky institutions combined and . . .

UofL named Tree Campus USA six years running March 2016

And yes • NCAA • Investigation of two employees • Institutions have issues / challenges 22

It has been tough . . . State appropriation since reform Gross State Appropriation History 204,000,000 Proposed 191,346,100 for 2016- 18 184,000,000 164,000,000 151,460,500 144,000,000 134,200,000 126,600,000 124,000,000 104,000,000 84,400,000 84,000,000 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018

Since FY2003- FY2016 – 13 State Budget Cuts But we have remained focused on our Mandate 6 strategies! for moving forward

We adopted strategies for moving forward through a tough fiscal environment (2005) Strategy one- cost management $130.1M in cost efficiencies “Picked low hanging fruit –but now…”

We adopted strategies for moving forward through a tough fiscal environment (2005) – BOT requested ULF . . . Strategy two- taking “underperforming assets and making them perform” ShelbyHurst Research Technology Park Business Services / Entrepreneurship

We adopted strategies for moving forward through a tough fiscal environment (2005) Strategy two- taking “underperforming assets and making them perform” J.D. Nichols Campus for Innovation and Entrepreneurship Healthcare / Bio-Technology

We adopted strategies for moving forward through a tough fiscal environment (2005) Strategy two- taking “underperforming assets and making them perform” Belknap Engineering and Applied Sciences Research Park Additive Manufacturing / Analytics / Renewable Energy / Logistics

We adopted strategies for moving forward through a tough fiscal environment (2005) Strategy three- increasing value from our research/IP Dr. Suzanne Ildstad Sold intellectual property that does not require immunosuppressant drugs for solid organ transplants to Novartis

We adopted strategies for moving forward through a tough fiscal environment (2005) Strategy four- use private sector to do what we are not good at We have added approximately 4,000 beds/new food venues

New patent on synthetic molecules brings researchers closer to new - PowerPoint PPT Presentation

New patent on synthetic molecules brings researchers closer to new periodontitis treatment January 2016 Donald Demuth, Ph.D., associate dean for research and enterprise, UofL School of Dentistry, and Frederick Luzzio, Ph.D., professor, UofL

SynBio Is Expensive iGEM is great. Brings synthetic biology to the masses. But its really

Innovation Support Thomas Bereuter IP2018 October 2018 European Patent Academy - target groups

5/25/2011 Patent Reform Topics Law & economic model for understanding patent law

N Destination i? 108 US 8,687,777 B1 Page 2 Related U.S. Application Data 5,572.581 A 1 1/1996

Disclosures: AORTICA Corporation; Co-Founder Benjamin W. Starnes, MD The Alexander Whitehill

c12) United States Patent US 9,521,255 Bl (10) Patent No.: Lavian et al. (45) Date of Patent:

Patent family - background Patent family - background Patent family - background 1883

c12) United States Patent US 8,345,835 Bl (10) Patent No.: Or-Bach et al. (45) Date of Patent:

c12) United States Patent US 8,548,135 Bl (10) Patent No.: Lavian et al. (45) Date of Patent:

c12) United States Patent US 8,054,952 Bl (10) Patent No.: Or-Bach et al. (45) Date of Patent:

Synthetic Networks Luke Osterritter losterritter@cmu.edu Center for Computational Analysis of

(12) United States Patent US 8,867,708 B1 (10) Patent N0.: *oa. 21, 2014 Lavian et a]. (45)

Are there new molecules Are there new molecules for Pseudomonas for Pseudomonas in the pipeline

RNA From Mathematical Models to Real Molecules 4. Experiments with RNA Molecules Peter

RNA From Mathematical Models to Real Molecules 3. Optimization and Evolution of RNA Molecules

lf r::::==1r _v;_,su_ph_one--,-----' ' c_l 108c 1047 106 102a 110 108n US

Client Alert OIG Publishes Work Plan for Fiscal Year 2010 Afgecting FDA-regulated Contact

HCA Prescription Drug Program Ray Hanley, HCA 626 8 th Avenue SE Olympia, WA 98504

Hawthorne Patient Assistance Fund Financial medication assistance for eligible transplant

in Canadas Public 2017/18 Drug Dr ug Plans Plans Presentation to the 2019 CADTH Symposium

Immunotherapy A new frontier Candace S. Johnson, PhD Immunotherapy is the new focus in

Cancure Limited Investor Presentation Series A Capital Raise Cancure Limited Series A Capital

Whats next in treatment of brain cancer patients? Testing NOX-A12 + Radiotherapy in a Phase

IAN CROCKER = TIM HOWARD 1 Research on My Opponent (from Argentina) Lionel Messi = Alfredo

New patent on synthetic molecules brings researchers closer to new - PowerPoint PPT Presentation

New patent on synthetic molecules brings researchers closer to new periodontitis treatment January 2016 Donald Demuth, Ph.D., associate dean for research and enterprise, UofL School of Dentistry, and Frederick Luzzio, Ph.D., professor, UofL

SynBio Is Expensive iGEM is great. Brings synthetic biology to the masses. But its really

Innovation Support Thomas Bereuter IP2018 October 2018 European Patent Academy - target groups

5/25/2011 Patent Reform Topics Law &amp; economic model for understanding patent law

N Destination i? 108 US 8,687,777 B1 Page 2 Related U.S. Application Data 5,572.581 A 1 1/1996

Disclosures: AORTICA Corporation; Co-Founder Benjamin W. Starnes, MD The Alexander Whitehill

c12) United States Patent US 9,521,255 Bl (10) Patent No.: Lavian et al. (45) Date of Patent:

Patent family - background Patent family - background Patent family - background 1883

c12) United States Patent US 8,345,835 Bl (10) Patent No.: Or-Bach et al. (45) Date of Patent:

c12) United States Patent US 8,548,135 Bl (10) Patent No.: Lavian et al. (45) Date of Patent:

c12) United States Patent US 8,054,952 Bl (10) Patent No.: Or-Bach et al. (45) Date of Patent:

Synthetic Networks Luke Osterritter losterritter@cmu.edu Center for Computational Analysis of

(12) United States Patent US 8,867,708 B1 (10) Patent N0.: *oa. 21, 2014 Lavian et a]. (45)

Are there new molecules Are there new molecules for Pseudomonas for Pseudomonas in the pipeline

RNA From Mathematical Models to Real Molecules 4. Experiments with RNA Molecules Peter

RNA From Mathematical Models to Real Molecules 3. Optimization and Evolution of RNA Molecules

lf r::::==1r _v;_,su_ph_one--,-----' ' c_l 108c 1047 106 102a 110 108n US

Client Alert OIG Publishes Work Plan for Fiscal Year 2010 Afgecting FDA-regulated Contact

HCA Prescription Drug Program Ray Hanley, HCA 626 8 th Avenue SE Olympia, WA 98504

Hawthorne Patient Assistance Fund Financial medication assistance for eligible transplant

in Canadas Public 2017/18 Drug Dr ug Plans Plans Presentation to the 2019 CADTH Symposium

Immunotherapy A new frontier Candace S. Johnson, PhD Immunotherapy is the new focus in

Cancure Limited Investor Presentation Series A Capital Raise Cancure Limited Series A Capital

Whats next in treatment of brain cancer patients? Testing NOX-A12 + Radiotherapy in a Phase

IAN CROCKER = TIM HOWARD 1 Research on My Opponent (from Argentina) Lionel Messi = Alfredo

5/25/2011 Patent Reform Topics Law & economic model for understanding patent law